AstraZeneca wins first FDA approval for systemic lupus drug in a decade
Bio Pharma Dive
AUGUST 2, 2021
The regulator cleared Saphnelo despite mixed clinical trial data, giving patients another option after the recent OK for a drug aimed at the autoimmune disease's severe side effects.
Let's personalize your content